2nd Quarter - Report

ONCOLOGY NURSING SOCIETY for ONCOLOGY NURSING SOCIETY

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Support for nursing education and LHHS Appropriations.

LobbyistCovered position, as disclosed
LESLIE GREENBERG —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Support for Oncology patient education legislation "Assuring and Improving Cancer Treatment Education and Cancer Symptom Managment Act of 2009"- HR 1927.

LobbyistCovered position, as disclosed
LESLIE GREENBERG —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1927 (111th)

Health Issues HCR

Testimony regarding opiod REMS-caution regarding new regulations that may place restrictions on patients who need opiods and to assure that patients with pain are able to receive the medication they need without undue restrictions.

LobbyistCovered position, as disclosed
LESLIE GREENBERG —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.